Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Rare mutations in non small cell lung cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 07.08.18
Views: 733

Dr Tom Stinchcombe - Duke Cancer Institute, Durham, USA

Dr Stinchcombe speaks to ecancer at BEST OF ASCO® 2018 MIAMI SYMPOSIUM about rare mutations in non small cell lung cancer.

He focusses on RET mutations and rearrangements, with the latest drug details and targeted areas.

Dr Stinchcombe continues to discuss HER2 and MET.

Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation